BNP Paribas Financial Markets’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
59,206
-65,011
| -52% | -$1.37M | ﹤0.01% | 2096 |
|
|
2025
Q1 | $2.03M | Buy |
124,217
+85,525
| +221% | +$1.4M | ﹤0.01% | 1677 |
|
|
2024
Q4 | $994K | Buy |
38,692
+10,543
| +37% | +$271K | ﹤0.01% | 2084 |
|
|
2024
Q3 | $892K | Sell |
28,149
-46,315
| -62% | -$1.47M | ﹤0.01% | 1885 |
|
|
2024
Q2 | $2.61M | Sell |
74,464
-48,551
| -39% | -$1.7M | ﹤0.01% | 1223 |
|
|
2024
Q1 | $5.4M | Sell |
123,015
-84,720
| -41% | -$3.72M | ﹤0.01% | 1001 |
|
|
2023
Q4 | $7.39M | Buy |
207,735
+155,179
| +295% | +$5.52M | 0.01% | 814 |
|
|
2023
Q3 | $1.42M | Buy |
52,556
+8,238
| +19% | +$222K | ﹤0.01% | 1540 |
|
|
2023
Q2 | $1.04M | Sell |
44,318
-12,374
| -22% | -$291K | ﹤0.01% | 1626 |
|
|
2023
Q1 | $778K | Buy |
56,692
+17,084
| +43% | +$235K | ﹤0.01% | 1903 |
|
|
2022
Q4 | $720K | Sell |
39,608
-13,733
| -26% | -$250K | ﹤0.01% | 1757 |
|
|
2022
Q3 | $796K | Buy |
53,341
+44,768
| +522% | +$668K | ﹤0.01% | 2026 |
|
|
2022
Q2 | $118K | Buy |
8,573
+4,480
| +109% | +$61.8K | ﹤0.01% | 2667 |
|
|
2022
Q1 | $45.8K | Sell |
4,093
-6,901
| -63% | -$77.2K | ﹤0.01% | 3002 |
|
|
2021
Q4 | $260K | Buy |
10,994
+3,940
| +56% | +$93.1K | ﹤0.01% | 2660 |
|
|
2021
Q3 | $180K | Buy |
7,054
+5,655
| +404% | +$144K | ﹤0.01% | 2491 |
|
|
2021
Q2 | $29.4K | Sell |
1,399
-5,286
| -79% | -$111K | ﹤0.01% | 2841 |
|
|
2021
Q1 | $157K | Buy |
6,685
+2,808
| +72% | +$66K | ﹤0.01% | 2598 |
|
|
2020
Q4 | $54.3K | Buy |
3,877
+199
| +5% | +$2.79K | ﹤0.01% | 2864 |
|
|
2020
Q3 | $46.2K | Buy |
3,678
+3,227
| +716% | +$40.5K | ﹤0.01% | 2879 |
|
|
2020
Q2 | $6.41K | Buy |
+451
| New | +$6.41K | ﹤0.01% | 3269 |
|